INTERNATIONAL PATENT: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS, NIERENZENTRUM HEIDELBERG E.V. FILES APPLICATION FOR "INHIBITORS OF EBV+ B CELL MIGRATION FOR TREATMENT AND/OR PREVENTION OF EBV ASSOCIATED DISEASE"

GENEVA, Feb. 2 -- DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (Im Neuenheimer Feld 28069120 Heidelberg), NIERENZENTRUM HEIDELBERG E.V. (Im Neuenheimer Feld 16269120 Heidelberg) filed a patent application (PCT/EP2025/060430) for "INHIBITORS OF EBV+ B CELL MIGRATION FOR TREATMENT AND/OR PREVENTION OF EBV ASSOCIATED DISEASE" on Apr 15, 2025. With publication no. WO/2026/021693, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DELECLUSE, Henri-Jacques (Deutsches Krebsforschungszentrum Stiftung des offentl...